1. Home
  2. DVA vs CPT Comparison

DVA vs CPT Comparison

Compare DVA & CPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • CPT
  • Stock Information
  • Founded
  • DVA 1994
  • CPT 1993
  • Country
  • DVA United States
  • CPT United States
  • Employees
  • DVA N/A
  • CPT N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • CPT Real Estate Investment Trusts
  • Sector
  • DVA Health Care
  • CPT Real Estate
  • Exchange
  • DVA Nasdaq
  • CPT Nasdaq
  • Market Cap
  • DVA 10.9B
  • CPT 12.6B
  • IPO Year
  • DVA 1995
  • CPT 1993
  • Fundamental
  • Price
  • DVA $136.95
  • CPT $115.58
  • Analyst Decision
  • DVA Hold
  • CPT Buy
  • Analyst Count
  • DVA 4
  • CPT 18
  • Target Price
  • DVA $157.00
  • CPT $129.89
  • AVG Volume (30 Days)
  • DVA 736.8K
  • CPT 852.7K
  • Earning Date
  • DVA 08-05-2025
  • CPT 07-31-2025
  • Dividend Yield
  • DVA N/A
  • CPT 3.62%
  • EPS Growth
  • DVA 14.90
  • CPT N/A
  • EPS
  • DVA 10.11
  • CPT 1.09
  • Revenue
  • DVA $12,968,524,000.00
  • CPT $1,562,268,000.00
  • Revenue This Year
  • DVA $6.46
  • CPT $2.48
  • Revenue Next Year
  • DVA $3.24
  • CPT $3.26
  • P/E Ratio
  • DVA $13.41
  • CPT $106.26
  • Revenue Growth
  • DVA 5.11
  • CPT 0.55
  • 52 Week Low
  • DVA $131.76
  • CPT $102.35
  • 52 Week High
  • DVA $179.60
  • CPT $127.69
  • Technical
  • Relative Strength Index (RSI)
  • DVA 44.92
  • CPT 45.83
  • Support Level
  • DVA $134.64
  • CPT $115.08
  • Resistance Level
  • DVA $138.26
  • CPT $116.86
  • Average True Range (ATR)
  • DVA 2.71
  • CPT 2.02
  • MACD
  • DVA 0.14
  • CPT -0.21
  • Stochastic Oscillator
  • DVA 54.56
  • CPT 20.28

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About CPT Camden Property Trust

Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 177 multifamily properties comprised of nearly 59,996 apartment homes across the United States.

Share on Social Networks: